Skip to Main Content

Paper Details

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.
Sci Transl Med
41
2022
COVID-19, GS-441524, GS-621763, MERS-, MERS-CoV, Middle East respiratory syndrome CoV, SARS, SARS-, SARS-CoV, SARS-CoV-2, coronavirus disease, human, human primary lung cell, human primary lung cell culture systems, lung cell lines, mice, molnupiravir, monoclonal, mouse, nucleoside, remdesivir, severe acute respiratory syndrome coronavirus, virus
Author NameAffiliation
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Stephanie A MontgomeryUniversity of North Carolina School of Medicine
Stephanie A MontgomeryLineberger Comprehensive Cancer Center, University of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
  • 1 - 5

Datasets

Release 1.2